BR
BioArctic AB (publ)
BRCTF · OTC
$35.00 -5.21% (-$1.92)
1M +9.98%
Market Cap 30.5B kr
P/E Ratio 289.14x
Div. Yield 0.62%
ROE 5.21%
Bulios Fair Price
$34.01
2.8% downside
Current Price
$35
Undervalued Fair Value Overvalued
According to Bulios Fair Price, BRCTF is currently trading close to its fair value. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
4/9Valuation
0 /100
Expensive P/E 289.14x
P/FCF 287.78x
EV/EBITDA 133.79x
Growth
100 /100
Growing Rev. growth 105.95%
Book val. growth 35.64%
EPS growth N/A
Profitability
80 /100
Strong Gross margin 93.17%
FCF margin 10.61%
Net margin 10.56%
Quality
25 /100
Poor ROIC 4.26%
Asset turnover 0.36x
ROE 5.21%
Debt
100 /100
Low Debt/Equity 0.04x
Net debt/EBITDA -4.45x
Current ratio 3.99x
Stability
16 /100
Unstable Beta -0.67x
Profitable years 1
Rev. volatility 375.16%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about BRCTF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Gunilla Christina Osswald
Employees
131
Headquarters
Stockholm
Upcoming events
25 NOV
Earnings
Upcoming earnings report